Kingma JH - Search Results

1

van der Hooft CS, Heeringa J, van Herpen G, Kors JA, Kingma JH, Stricker BH. van der Hooft CS, et al. Among authors: kingma jh. J Am Coll Cardiol. 2004 Dec 7;44(11):2117-24. doi: 10.1016/j.jacc.2004.08.053. J Am Coll Cardiol. 2004. PMID: 15582307 Free article. Review.

2

Prolonged QTc interval and risk of sudden cardiac death in a population of older adults.

Straus SM, Kors JA, De Bruin ML, van der Hooft CS, Hofman A, Heeringa J, Deckers JW, Kingma JH, Sturkenboom MC, Stricker BH, Witteman JC. Straus SM, et al. Among authors: kingma jh. J Am Coll Cardiol. 2006 Jan 17;47(2):362-7. doi: 10.1016/j.jacc.2005.08.067. J Am Coll Cardiol. 2006. PMID: 16412861 Free article.

3

Corticosteroids and the risk of atrial fibrillation.

van der Hooft CS, Heeringa J, Brusselle GG, Hofman A, Witteman JC, Kingma JH, Sturkenboom MC, Stricker BH. van der Hooft CS, et al. Among authors: kingma jh. Arch Intern Med. 2006 May 8;166(9):1016-20. doi: 10.1001/archinte.166.9.1016. Arch Intern Med. 2006. PMID: 16682576

4

Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death.

Straus SM, Sturkenboom MC, Bleumink GS, Dieleman JP, van der Lei J, de Graeff PA, Kingma JH, Stricker BH. Straus SM, et al. Among authors: kingma jh. Eur Heart J. 2005 Oct;26(19):2007-12. doi: 10.1093/eurheartj/ehi312. Epub 2005 May 11. Eur Heart J. 2005. PMID: 15888497

5

Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study.

Hagens VE, Ranchor AV, Van Sonderen E, Bosker HA, Kamp O, Tijssen JG, Kingma JH, Crijns HJ, Van Gelder IC; RACE Study Group. Hagens VE, et al. Among authors: kingma jh. J Am Coll Cardiol. 2004 Jan 21;43(2):241-7. doi: 10.1016/j.jacc.2003.08.037. J Am Coll Cardiol. 2004. PMID: 14736444 Free article.

6

Apolipoprotein E epsilon4 allele is associated with left ventricular systolic dysfunction.

Bleumink GS, van Duijn CM, Kingma JH, Witteman JC, Hofman A, Stricker BH. Bleumink GS, et al. Among authors: kingma jh. Am Heart J. 2004 Apr;147(4):685-9. doi: 10.1016/j.ahj.2003.11.016. Am Heart J. 2004. PMID: 15077085

7

Mortality in patients with hypertension on angiotensin-I converting enzyme (ACE)-inhibitor treatment is influenced by the ACE insertion/deletion polymorphism.

Bleumink GS, Schut AF, Sturkenboom MC, van Duijn CM, Deckers JW, Hofman A, Kingma JH, Witteman JC, Stricker BH. Bleumink GS, et al. Among authors: kingma jh. Pharmacogenet Genomics. 2005 Feb;15(2):75-81. doi: 10.1097/01213011-200502000-00003. Pharmacogenet Genomics. 2005. PMID: 15861031

8

Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function.

Suttorp MJ, Kingma JH, Koomen EM, van 't Hof A, Tijssen JG, Lie KI. Suttorp MJ, et al. Among authors: kingma jh. Am J Cardiol. 1993 Mar 15;71(8):710-3. doi: 10.1016/0002-9149(93)91015-a. Am J Cardiol. 1993. PMID: 8447270

9

Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm.

Suttorp MJ, Kingma JH, Lie-A-Huen L, Mast EG. Suttorp MJ, et al. Among authors: kingma jh. Am J Cardiol. 1989 Mar 15;63(11):693-6. doi: 10.1016/0002-9149(89)90253-1. Am J Cardiol. 1989. PMID: 2493733 Clinical Trial.

10

Efficacy and safety of intravenous dofetilide for rapid termination of atrial fibrillation and atrial flutter.

Lindeboom JE, Kingma JH, Crijns HJ, Dunselman PH. Lindeboom JE, et al. Among authors: kingma jh. Am J Cardiol. 2000 Apr 15;85(8):1031-3. doi: 10.1016/s0002-9149(99)00927-3. Am J Cardiol. 2000. PMID: 10760352 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

115 results

Search Page